Merck Aktie
137,45
EUR
-0,85
EUR
-0,61
%
Kursziele der Merck-Aktie in EUR
Das durchschnittliche Kursziel beinhaltet alle Analysen eines Analysten und nicht nur die jeweils aktuellste Analyse, die im Chart dargestellt wird.
Diese Analysten bewerten die Merck-Aktie
| Analyst | Kursziel | Abstand Kursziel | Datum | |
|---|---|---|---|---|
| JP Morgan Chase & Co. | 190,00 EUR | +37,48% | 11.12.2024 | |
| DZ BANK | - | - | 02.12.2024 | |
| Deutsche Bank AG | 180,00 EUR | +30,25% | 15.11.2024 | |
| UBS AG | 190,00 EUR | +37,48% | 15.11.2024 | |
| Goldman Sachs Group Inc. | 196,00 EUR | +41,82% | 15.11.2024 | |
| Jefferies & Company Inc. | 180,00 EUR | +30,25% | 14.11.2024 | |
| Bernstein Research | 176,00 EUR | +27,35% | 18.10.2024 | |
| Barclays Capital | 195,00 EUR | +41,10% | 01.08.2024 |
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| 3M Co. | 0 | 0 | 0 | - | - |
| Abbott Laboratories | 0 | 0 | 0 | - | - |
| AstraZeneca PLC | 5 | 4 | 0 | 138,26 GBP | +34,81% |
| BASF | 8 | 3 | 0 | 52,84 EUR | +24,11% |
| Bayer | 1 | 9 | 0 | 27,22 EUR | +43,20% |
| BB Biotech AG | 0 | 0 | 0 | - | - |
| Beiersdorf AG | 7 | 3 | 1 | 144,00 EUR | +16,88% |
| Biotest AG Vz. | 0 | 0 | 0 | - | - |
| Bristol-Myers Squibb Co. | 0 | 0 | 0 | - | - |
| Clorox Co., The | 0 | 0 | 0 | - | - |
| Colgate-Palmolive Co. | 0 | 0 | 0 | - | - |
| Eli Lilly | 1 | 0 | 0 | 994,00 USD | +29,47% |
| Gilead Sciences Inc. | 0 | 0 | 0 | - | - |
| GSK PLC Registered Shs | 2 | 6 | 1 | 17,14 GBP | +29,85% |
| H. B. Fuller Co. | 0 | 0 | 0 | - | - |
| H&R GmbH & Co. KGaA | 0 | 1 | 0 | - | - |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| L'Oréal S.A. (L'Oreal, L Oreal) | 4 | 4 | 2 | 408,44 EUR | +21,43% |
| LANXESS AG | 5 | 2 | 3 | 28,11 EUR | +20,33% |
| Merck Co. | 0 | 0 | 0 | - | - |
| Merck KGaA | 7 | 1 | 0 | 186,71 EUR | +35,10% |
| Novartis AG | 3 | 5 | 1 | 98,86 CHF | +14,00% |
| Pfizer Inc. | 3 | 3 | 0 | 31,20 USD | +18,36% |
| Procter & Gamble Co. | 0 | 0 | 0 | - | - |
| Reckitt Benckiser Plc | 4 | 6 | 0 | 54,32 GBP | +12,98% |
| Roche Holding AG (Inhaberaktie) | 0 | 0 | 0 | - | - |
| Sanofi S.A. | 5 | 2 | 1 | 109,86 EUR | +21,54% |
| STADA | 0 | 0 | 0 | - | - |
| Takeda Pharmaceutical Co. Ltd. | 0 | 0 | 0 | - | - |
| Unilever plc | 4 | 4 | 2 | 47,93 GBP | - |
| WACKER CHEMIE AG | 5 | 3 | 0 | 112,14 EUR | +65,74% |